Viatris’ presbyopia drug clears second Phase III trial
There are only two therapies approved for presbyopia in the US.
27 June 2025
27 June 2025
There are only two therapies approved for presbyopia in the US.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.